Purchase Order 75N92C22P00040

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

This is a $9,950.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to R&D Systems, Inc. for the supply of recombinant human PSG-1 protein. R&D Systems, a subsidiary of the parent company Bio-Techne Corporation, is a manufacturer and supplier of high-quality research reagents and instruments for the biomedical research community. The company has been awarded numerous...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide custom-produced biotinylated and non-biotinylated proteins. The $45,035.54 contract supports the mission of the Vaccine Research Center, which had previously used Genscript's proteins in downstream experiments. The contract has no set-aside designation. Genscript, based in Piscataway,...

This firm fixed price purchase order was awarded by the National Institutes of Health National Cancer Institute to Genscript USA Inc. for $30,280. The contract is for the acquisition of recombinant antibody against mouse ErbB2 (HER2) domain IV via custom protein production services. Specifically, Genscript will immunize rabbits with the antigen protein, collect B cell clones to screen for binding to mouse HER2, collect supernatants from 20 antibody clones, and produce and purify the...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Research And Diagnostic Systems, Inc. (R&D Systems), doing business as R&D Systems. The $14,081.90 contract is for the delivery of recombinant protein and has a total small business set-aside designation. R&D Systems is a manufacturer of research materials including proteins,...

This is a firm fixed-price Purchase Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Research And Diagnostic Systems, Inc. (doing business as R&D Systems), a manufacturer of research reagents and instruments. The $23,380.00 contract is for the delivery of recombinant protein. The contract has a total small business set-aside designation. R&D Systems, a subsidiary of...

The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $24,045.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&D Systems) for custom protein development services. R&D Systems is a for-profit manufacturer of antibodies, ELISA kits, proteins, and other research materials that has provided a range of products and services to various HHS agencies, including the NIH, Centers...

This is a $92,322 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Proimmune, Inc., a small business contractor, to provide services to the FDA's Center for Biologics Evaluation and Research (CBER), Office of Division of Plasma Protein Therapeutics' (DPPT) / Hemostasis Branch (HB). The contract is for determining a reliable and comprehensive identification of FVIII-derived peptides to compare processing by antigen presenting cells between wild-type and...

This is a $13,975 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Research And Diagnostic Systems, Inc. (R&D Systems) for recombinant human protein PSG1. The award did not have a set-aside designation. R&D Systems is a for-profit manufacturer and a subsidiary of the Bio-Techne Corporation. R&D Systems has received numerous prior NIH contracts for...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing, custom design chimeric plasmid, and custom proteins. The $249,785.00 contract has a completion date of September 29, 2022 and was awarded on September 30, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...